id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0015-0003,FDA,FDA-2011-N-0015,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Application Form for Orphan Medicinal Product Designation",Notice,General Notice,2011-11-14T05:00:00Z,2011,11,2011-11-14T05:00:00Z,,2011-11-14T14:46:40Z,2011-29296,0,0,0900006480f6bb8e
FDA-2011-N-0015-0002,FDA,FDA-2011-N-0015,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Orphan Drugs; Common EMA/FDA Application formfor Orphan Medicinal Product Designation",Notice,N-Notice,2011-05-13T04:00:00Z,2011,5,2011-05-13T04:00:00Z,2011-06-14T03:59:59Z,2011-05-13T13:18:38Z,2011-11744,0,0,0900006480c79eda
FDA-2011-N-0015-0001,FDA,FDA-2011-N-0015,"Agency Information Collection Activities; Proposals, Submissions, and Approvals Form for Orphan Medicinal Product Designation (Form FDA 3671)",Notice,N-Notice,2011-01-21T05:00:00Z,2011,1,2011-01-21T05:00:00Z,2011-03-23T03:59:59Z,2011-01-21T14:28:36Z,2011-1270,0,0,0900006480bcfb66